Asian Myeloproliferative Neoplasm (MPN) Registry

Recruiting Observational Study
Myeloproliferative Neoplasm Polycythemia Vera Essential Thrombocythemia Post-polycythemia Vera Myelofibrosis Post-essential Thrombocythemia Myelofibrosis Primary Myelofibrosis Primary Myelofibrosis, Prefibrotic Stage Primary Myelofibrosis, Fibrotic Stage
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
1,000 (estimated)
Sponsor
The University of Hong Kong · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This is a multinational, multicenter, prospective and retrospective, observational, cohort study of patients with myeloproliferative neoplasm.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Age ≥ 18 years old at the time of diagnosis of MPN. 2. Subject was diagnosed with one of the following disorders according to the 2017 WHO classification (for patients diagnosed before 2017, the bone marrow reports will be re-evaluated according to the 2017 WHO classification…
Contacts

Harinder Gill, MD

+852 22554542

gillhsh@hku.hk

CONTACT